Tag: NYSE:NVS

FB Nasdaq FB Facebook
Finance

Investor’s Watch List: Gilead Sciences (NASDAQ:GILD), Consolidated Communications Holdings (NASDAQ:CNSL), GT Advanced Technologies Inc (NASDAQ:GTAT), Novartis (NYSE:NVS)

Gilead Sciences, Inc. (NASDAQ:GILD) company on Mar. 28 announced that it has elected to settle its conversion obligations in connection with any 1.00% Senior Convertible Notes due 2014 (the “Notes”) submitted for conversion on or after February 1, 2014 entirely in cash. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was 3.92% in last session and finished the day at $73.64. Traded volume was 19,465,500 million shares … Continue reading Investor’s Watch List: Gilead Sciences (NASDAQ:GILD), Consolidated Communications Holdings (NASDAQ:CNSL), GT Advanced Technologies Inc (NASDAQ:GTAT), Novartis (NYSE:NVS)

Colin Pettis
Finance

Healthcare Touched New Highs: Select Medical Holdings (NYSE:SEM), Corcept Therapeutics Incorporated (NASDAQ:CORT), Novartis (NYSE:NVS), Becton, Dickinson (NYSE:BDX)

Select Medical Holdings Corporation (NYSE:SEM), announced that the company has completed its private placement of $110.0 million in aggregate principal amount of its 6.375% senior notes due 2021 (the “Additional Notes”) as additional notes under the indenture pursuant to which it previously issued $600.0 million of 6.375% senior notes due 2021. Select intends to use the net proceeds of the offering of the Additional Notes, … Continue reading Healthcare Touched New Highs: Select Medical Holdings (NYSE:SEM), Corcept Therapeutics Incorporated (NASDAQ:CORT), Novartis (NYSE:NVS), Becton, Dickinson (NYSE:BDX)

John Bellich